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SCIENTIFIC LETTER
Helicobacter pylori and atrial fibrillation: a possible
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R
ecent advances have raised the hope of effective
pharmacological or non-pharmacological treatments of
atrial fibrillation (AF), and of better understanding of
the pathophysiological mechanisms involved in the initiation
and persistence of the arrhythmia. Inflammatory changes in
the atrial structure have been observed after cardiac surgery1
but also in patients with non-postoperative AF. Atrial
histological abnormalities have been shown to be present in
lone AF and in 66% of patients the biopsies were compatible
with myocarditis.2
Recently C reactive protein (CRP) concentration, a sensi-
tive marker of systemic inflammation, was found to be twice
as high in patients with AF as in a control group with no
history of atrial arrhythmia.3 A potential non-cardiovascular
disease that predisposes to AF may be chronic gastritis
caused by chronic Helicobacter pylori infection. Thus, we
hypothesised that H pylori may be involved in the chronic
atrial inflammation resulting in AF.
This study aimed: (1) to confirm the data previously
reported that showed higher concentrations of CRP in
patients with AF; and (2) to assess the possible association
between H pylori infection and AF in patients without
demonstrable structural cardiac disease, by comparing them
with a group of normal healthy volunteers.
METHODS
For this case–control study we enrolled 59 consecutive
patients with a paroxysmal or persistent form of AF4 who
were admitted to our cardiology department for cardioversion
and electrophysiological study. This group included patients
without structural heart disease even though some patients
were prescribed medication for hypertension.
We also investigated a control group of 45 healthy
volunteers who were assessed from their medical history
and a clinical examination to have no history of atrial
arrhythmias or concomitant acute or chronic disease.
Exclusion criteria were myocardial infarction, prior cardi-
othoracic surgery, ischaemic heart disease, valvar disease,
thyroid dysfunction, congenital heart disease, diabetes, and
acute or chronic infections. All patients underwent a physical
examination, ECG, echocardiography, electrophysiological
study, routine laboratory tests, thyroid function tests, a
serological test for H pylori, and CRP determination (not high
sensitivity).
All chemical tests and CRP were measured on a Roche
Modular system. For CRP determination, we used a homo-
geneous immunoturbidimetric assay with calibration mate-
rial referring to CRM470 IFCC International Reference
Standard with a 0–6 mg/l reference range. IgG antibodies to
H pylori were assayed by the enzyme linked immunosorbent
assay (ELISA) H pylori IgG kit (Adaltis Italia, Casalecchio di
Reno, Bologna, Italy) on a semiautomatic ELISA processor
(Labotech, Adaltis Italia) with an analytical range of
5–100 IU/ml and a cut off established at 15 IU/ml.
Results are presented as mean (SD) for continuous
normally distributed variables, as median (interquartile
range) for non-normally distributed data, and as percentages
for categorical data. Groups were compared by unpaired t test
or one way analysis of variance for normally distributed
variables, and by the Kolmogorov-Smirnov test or Mann-
Whitney test where data were not normally distributed. To
account for covariate effects between groups, the analysis of
variance was adjusted for covariates after natural log
transformation of skewed distribution. Data were analysed
with SPSS (SPSS Inc, Chicago, Illinois, USA).
RESULTS
Table 1 shows the mean (SD) age of the AF and the control
groups enrolled between March 2002 and January 2003,
together with other demographic and clinical characteristics.
There were no significant differences in the mean ages of the
two groups. There was a difference in the number of patients
being treated for hypertension, which was larger in the AF
group than in the control group. There were no significant
differences between the groups regarding the presence of
traditional risk factors, cholesterol, low density lipoprotein
cholesterol, and triglycerides.
Table 2 shows the mean (SD) age and demographic and
clinical characteristics of the group with chronic AF
subdivided into persistent (n = 29) and paroxysmal
(n = 30) AF. Patients with persistent AF were older than
patients with paroxysmal AF and they had a higher
prevalence of treated hypertension. There were no significant
differences between the groups regarding the presence of
traditional risk factors.
In the AF group H pylori seropositivity (97.2 (50.5–
100.0) IU/ml) and CRP (8 (6–10) mg/l) were significantly
higher (p , 0.001) than in the control group (5.3 (5.0–
33.9) IU/ml and 1 (0–2) mg/l, respectively).
Table 1 Demographic and clinical data of patients with
atrial fibrillation (AF) and controls
AF group
(n = 59)
Control group
(n = 45) p Value
Age (years) 64.28 (12.69) 64.25 (12.95)
Patients treated for
hypertension
33 (55%) 5 (11%)
Biochemical analyses
Cholesterol (mmol/l) 5.034 (0.89) 5.043 (1.33) 0.966
Triglycerides (mmol/l) 1.65 (0.91) 1.43 (0.76) 0.207
LDL (mmol/l) 2.93 (0.74) 3.28 (1.73) 0.890
Data are mean (SD) or number (%).
LDL, low density lipoprotein.
Abbreviations: AF, atrial fibrillation; CRP, C reactive protein; ELISA,
enzyme linked immunosorbent assay
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H pylori seropositivity and CRP were both significantly
higher (100 (72.6–100.0) IU/ml v 60.2 (35.9–100.0) IU/ml,
p = 0.027, and 9 (7–11) mg/l v 7 (6–10) mg/l, p = 0.041,
respectively) in patients with persistent AF than in those
with paroxysmal AF after adjustment for differences in age in
the groups with persistent and paroxysmal AF as described
above.
DISCUSSION
This pilot study was proposed after prolonged clinical
observations that a high percentage of patients with AF
admitted to our cardiology department had gastric problems.
Following this observations, we introduced as standard
practice the determination of antibodies to H pylori. We soon
realised AF and H pylori infection were associated. We
therefore established the study reported here, which we
believe to be the first that shows a highly significant
correlation between AF and H pylori. The association between
AF and H pylori was very strong in patients with persistent
AF. In addition, we report high concentrations of CRP, which
confirm the presence of systemic inflammation in patients
with AF, which leads us to hypothesise that H pylori infection
may be the substrate of this systemic inflammation mani-
festing in AF. Chung and colleagues3 were the first to
document an inflammatory state in patients with AF.
H pylori is a very strong bacterium, with features that allow
it to cross gastric mucus and to attach to epithelial cells,
thereby evading the immune response. H pylori infection is
responsible for determining an important systemic and
mucosal humoral response, but these antibodies do not
eradicate the infection and may contribute to tissue damage.5
Different H pylori strains can determine the specific systemic
antibody response in infected patients. Some patients with H
pylori have autoantibodies to the H+/K+-ATPase of gastric
parietal cells that can determine corpus atrophy.6 Considering
that there is a similarity between H+/K+-ATPase, the proton
pump of gastric cells, and Na+/K+-ATPase, the pump of
cardiac cells, which are inhibited by cardiac glycoside such as
digoxin, an interesting hypothesis is that these autoantibo-
dies to H+/K+-ATPase may also be antibodies to Na+/K+-
ATPase, thus determining atrial damage. In fact, cardiac Na+/
K+-ATPase and H+/K+-ATPase have a similar 35 kDa glyco-
protein necessary for their catalytic activity. The role of these
pumps is to maintain ionic homeostasis by hydrolysing ATP
and therefore loss of this balance may trigger AF by
determining abnormal automaticity or triggered activity that
causes delay after depolarisation inducing very rapid pre-
mature atrial contractions. Several issues remain unresolved.
We have shown the highly significant link between AF and
H pylori in our relatively small sample and confirmed that
CRP is a good marker for the inflammatory process. More
data will be necessary from controlled studies to further
identify how H pylori can influence the pathogenesis of AF.
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Table 2 Demographic and clinical data for patients with
persistent AF and paroxysmal AF
Persistent AF
(n = 29)
Paroxysmal AF
(n = 30) p Value
Age (years) 68.17 (11.68) 60.60 (12.91) 0.022
Hypertension 22 (75.9%) 11 (36.7%) 0.009
Biochemical analyses
Cholesterol (mmol/l) 5.034 (0.89) 4.82 (0.95) 0.950
Triglycerides (mmol/l) 1.65 (0.91) 1.44 (0.95) 0.828
LDL (mmol/l) 2.93 (0.74) 2.78 (2.17) 0.736
Data are mean (SD) of number (%).
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